Recently, Hong et al. [17] demonstrated that TNS2 is downregulated in most human cancers, and low expression is associated with poor survival and silencing of TNS2-promoted tumor growth in HeLa cell-xenografted NSG mice. The gene discussed is TNS2; the disease is cancer.